A systematic review of the impact of including both waist and hip circumference in risk models for cardiovascular diseases, diabetes and mortality

Obesity Reviews

Volumn 14, Issue 1, 2013, Pages 86-94

  Cameron, A J ^a   Magliano, D J ^b   Soderberg S ^b,c  

^a DEAKIN UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Hip circumference; Mortality; Obesity; Waist circumference

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ANTHROPOMETRIC PARAMETERS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DATA BASE; DISEASE ASSOCIATION; FOLLOW UP; HEART DISEASE; HIP CIRCUMFERENCE; HUMAN; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROPORTIONAL HAZARDS MODEL; REVIEW; RISK ASSESSMENT; SMOKING; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; VENOUS THROMBOEMBOLISM; WAIST CIRCUMFERENCE;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; RISK ASSESSMENT; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84871228682     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2012.01051.x     Document Type: Review

References (56)

1. Whitlock G, Lewington S, Sherliker P etal. Body-mass index and cause-specific mortality in 900, 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-1096.
2. Arnlov J, Ingelsson E, Sundstrom J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2009; 121: 230-236.
3. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. J Am Med Assoc 2005; 293: 1861-1867.
4. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998; 338: 1-7.
5. Manson J, Willett W, Stampfer M etal. Body weight and mortality among women. N Engl J Med 1995; 333: 677-685.
6. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW, Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105.
7. Jee SH, Sull JW, Park J etal. Body-mass index and mortality in Korean men and women. N Engl J Med 2006; 355: 779-787.
8. Adams KF, Schatzkin A, Harris TB etal. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355: 763-778.
9. Pischon T, Boeing H, Hoffmann K etal. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105-2120.
10. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008; 117: 1658-1667.
11. Cameron AJ, Dunstan DW, Owen N etal. Health and mortality consequences of abdominal obesity: evidence from the AusDiab study. Med J Aust 2009; 191: 202-208.
12. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-887.
13. Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord 2004; 28: 402-409.
14. Lissner L, Bjorkelund C, Heitmann BL, Seidell JC, Bengtsson C. Larger hip circumference independently predicts health and longevity in a Swedish female cohort. Obes Res 2001; 9: 644-646.
15. Parker ED, Pereira MA, Stevens J, Folsom AR. Association of hip circumference with incident diabetes and coronary heart disease: the Atherosclerosis Risk in Communities study. Am J Epidemiol 2009; 169: 837-847.
16. Canoy D, Boekholdt SM, Wareham N etal. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation 2007; 116: 2933-2943.
17. Yusuf S, Hawken S, Ounpuu S etal. Obesity and the risk of myocardial infarction in 27, 000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649.
18. Bigaard J, Frederiksen K, Tjonneland A etal. Waist and hip circumferences and all-cause mortality: usefulness of the waist-to-hip ratio? Int J Obes Relat Metab Disord 2004; 28: 741-747.
19. Mason C, Craig CL, Katzmarzyk PT. Influence of central and extremity circumferences on all-cause mortality in men and women. Obesity (Silver Spring) 2008; 16: 2690-2695.
20. Heitmann BL, Frederiksen P, Lissner L. Hip circumference and cardiovascular morbidity and mortality in men and women. Obes Res 2004; 12: 482-487.
21. Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 2010; 34: 949-959.
22. Welborn TA, Dhaliwal SS, Bennett SA. Waist-hip ratio is the dominant risk factor predicting cardiovascular death in Australia. Med J Aust 2003; 179: 580-585.
23. Wormser D, Kaptoge S, Di Angelantonio E etal. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011; 377: 1085-1095.
24. Dalton M, Cameron AJ, Zimmet PZ etal. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 2003; 254: 1-9.
25. Staiano AE, Reeder BA, Elliott S etal. Body mass index versus waist circumference as predictors of mortality in Canadian adults. Int J Obes (Lond) 2012; doi: 10.1038/ijo.2011.268. [Epub ahead of print].
26. Czernichow S, Kengne AP, Stamatakis E, Hamer M, Batty GD. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82, 864 participants from nine cohort studies. Obes Rev 2011; 12: 680-687.
27. Allison DB, Paultre F, Goran MI, Poehlman ET, Heymsfield SB. Statistical considerations regarding the use of ratios to adjust data. Int J Obes Relat Metab Disord 1995; 19: 644-652.
28. Heitmann BL, Lissner L. Hip Hip Hurrah! Hip size inversely related to heart disease and total mortality. Obes Rev 2011; 12: 478-481.
29. Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement. PLoS Med 2009; 6: e1000097. URL http://www.prisma-statement.org/2.1.2%20-%20PRISMA%202009%20Checklist.pdf (accessed 23 July 2012).
30. Heitmann BL, Frederiksen P. Thigh circumference and risk of heart disease and premature death: prospective cohort study. BMJ 2009; 339: b3292.
31. Yang L, Kuper H, Weiderpass E. Anthropometric characteristics as predictors of coronary heart disease in women. J Intern Med 2008; 264: 39-49.
32. Baik I, Ascherio A, Rimm EB etal. Adiposity and mortality in men. Am J Epidemiol 2000; 152: 264-271.
33. Petursson H, Sigurdsson JA, Bengtsson C, Nilsen TI, Getz L. Body configuration as a predictor of mortality: comparison of five anthropometric measures in a 12 year follow-up of the Norwegian HUNT 2 study. PLoS ONE 2011; 6: e26621.
34. Conway B, Xiang YB, Villegas R etal. Hip circumference and the risk of type 2 diabetes in middle-aged and elderly men and women: the Shanghai women and Shanghai men's health studies. Ann Epidemiol 2011; 21: 358-366.
35. Janghorbani M, Amini M. Associations of hip circumference and height with incidence of type 2 diabetes: the Isfahan diabetes prevention study. Acta Diabetol 2011; doi: 10.1007/s00592-011-0351-4. [Epub ahead of print].
36. de Koning L, Gerstein HC, Bosch J etal. Anthropometric measures and glucose levels in a large multi-ethnic cohort of individuals at risk of developing type 2 diabetes. Diabetologia 2010; 53: 1322-1330.
37. Cameron AJ, Magliano DJ, Shaw JE etal. The influence of hip circumference on the relationship between abdominal obesity and mortality. Int J Epidemiol 2012; 41: 484-494.
38. Sauvaget C, Ramadas K, Thomas G, Vinoda J, Thara S, Sankaranarayanan R. Body mass index, weight change and mortality risk in a prospective study in India. Int J Epidemiol 2008; 37: 990-1004.
39. Hosegood V, Campbell OM. Body mass index, height, weight, arm circumference, and mortality in rural Bangladeshi women: a 19-y longitudinal study. Am J Clin Nutr 2003; 77: 341-347.
40. Pierce BL, Kalra T, Argos M etal. A prospective study of body mass index and mortality in Bangladesh. Int J Epidemiol 2010; 39: 1037-1045.
41. Zheng W, McLerran DF, Rolland B etal. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med 2011; 364: 719-729.
42. Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjonneland A, Overvad K. Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. Circulation 2009; 120: 1850-1857.
43. Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 2006; 35: 83-92.
44. Seidell JC, Perusse L, Despres JP, Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am J Clin Nutr 2001; 74: 315-321.
45. Chowdhury B, Lantz H, Sjostrom L. Computed tomography-determined body composition in relation to cardiovascular risk factors in Indian and matched Swedish males. Metabolism 1996; 45: 634-644.
46. Chan J, Rimm E, Colditz G, Stampfer M, Willett W. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961-969.
47. Carey VJ, Walters EE, Colditz GA etal. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol 1997; 145: 614-619.
48. Leitzmann MF, Moore SC, Koster A etal. Waist circumference as compared with body-mass index in predicting mortality from specific causes. PLoS ONE 2011; 6: e18582.
49. Berentzen TL, Angquist L, Kotronen A etal. Waist circumference adjusted for body mass index and intra-abdominal fat mass. PLoS ONE 2012; 7: e32213.
50. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83: 356-362.
51. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
52. Wallis EJ, Ramsay LE, Ul Haq I etal. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population. BMJ 2000; 320: 671-676.
53. D'Agostino RB, Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. J Am Med Assoc 2001; 286: 180-187.
54. D'Agostino RB, Sr, Vasan RS, Pencina MJ etal. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-753.
55. Grundy SM, Balady GJ, Criqui MH etal. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 1998; 97: 1876-1887.
56. Day N, Oakes S, Luben R et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999; 80(Suppl. 1): 95-103.